TYRA · Categories · Form 4

TYRA - SEC Form 4 insider transactions

Tyra Biosciences Inc. (TYRA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for TYRA

• 6d
  SEC Form 4 filed by Dable Habib J

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 30d
  SEC Form 4 filed by Kaplan Gilla

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 40d
  Chief Financial Officer Fuhrman Alan was granted 1,376 shares, increasing direct ownership by 9% to 16,164 units (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 40d
  President and CEO Harris Todd was granted 1,463 shares, increasing direct ownership by 0.11% to 1,358,631 units (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 72d
  Chief Discovery Officer Bensen Daniel sold $262,965 worth of shares (8,000 units at $32.87), decreasing direct ownership by 5% to 146,981 units (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 96d
  Chief Discovery Officer Bensen Daniel sold $228,186 worth of shares (8,000 units at $28.52), decreasing direct ownership by 5% to 154,981 units (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 128d
  Director More Robert J sold $250,000 worth of shares (10,000 units at $25.00) (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 131d
  Chief Discovery Officer Bensen Daniel sold $181,159 worth of shares (8,000 units at $22.64), decreasing direct ownership by 5% to 162,981 units (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 146d
  SEC Form 4 filed by Chief Operating Officer Ashar Bhavesh

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 152d
  Director More Robert J sold $5,000,026 worth of shares (246,871 units at $20.25) (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 158d
  Chief Operating Officer Bensen Daniel sold $2,030,923 worth of shares (125,589 units at $16.17), decreasing direct ownership by 42% to 170,981 units (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 160d
  Chief Operating Officer Bensen Daniel sold $2,108,067 worth of shares (131,411 units at $16.04), decreasing direct ownership by 31% to 296,570 units (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 221d
  Chief Financial Officer Fuhrman Alan was granted 701 shares, increasing direct ownership by 5% to 14,788 units (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 262d
  SEC Form 4 filed by Chief Financial Officer Fuhrman Alan

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 262d
  SEC Form 4 filed by Chief Operating Officer Bensen Daniel

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 262d
  SEC Form 4 filed by Chief Medical Officer Warner Douglas J

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 262d
  SEC Form 4 filed by President and CEO Harris Todd

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 310d
  Director Kaplan Gilla sold $93,700 worth of shares (9,578 units at $9.78), decreasing direct ownership by 25% to 28,231 units (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 314d
  Director Kaplan Gilla sold $534,563 worth of shares (51,814 units at $10.32), decreasing direct ownership by 58% to 37,809 units (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 328d
  SEC Form 4 filed by Director Ra Capital Management, L.P.

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 328d
  SEC Form 4 filed by Director Moran Susan

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 328d
  SEC Form 4 filed by Director More Robert J

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 328d
  SEC Form 4 filed by Director Rothenberg Stephen Michael

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 328d
  SEC Form 4 filed by Director Simson Jake

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 328d
  SEC Form 4 filed by Director Kaplan Gilla

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 328d
  SEC Form 4 filed by Director Verjee Rehan

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 404d
  President and CEO Harris Todd was granted 1,241 shares, increasing direct ownership by 0.09% to 1,357,168 units (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 404d
  Chief Financial Officer Fuhrman Alan was granted 1,238 shares, increasing direct ownership by 10% to 14,087 units (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 443d
  Director Kjellson Nina S sold $74,324 worth of shares (5,401 units at $13.76) (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 450d
  SEC Form 4 filed by Director Gulfo Adele M.

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 454d
  Director Kjellson Nina S sold $78,466 worth of shares (4,825 units at $16.26) (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 460d
  Director Kjellson Nina S sold $409,645 worth of shares (25,041 units at $16.36) (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 516d
  Director Kjellson Nina S sold $88,773 worth of shares (5,272 units at $16.84) (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 534d
  Director Kjellson Nina S sold $1,284,133 worth of shares (74,582 units at $17.22) (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 536d
  Director Kjellson Nina S sold $194,248 worth of shares (11,569 units at $16.79) (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 541d
  Director Kjellson Nina S sold $2,272,292 worth of shares (138,107 units at $16.45) and sold $10,364 worth of Commmon Stock (604 units at $17.16) (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 551d
  Boxer Capital Management, Llc returned 2,000,000 shares to the company (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 551d
  President and CEO Harris Todd sold $1,711,247 worth of shares (62,720 units at $27.28), decreasing direct ownership by 4% to 1,355,927 units (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 551d
  Director Ra Capital Management, L.P. disposed of 1,000,000 shares (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 556d
  President and CEO Harris Todd sold $1,513,271 worth of shares (58,726 units at $25.77), decreasing direct ownership by 4% to 1,418,647 units (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 571d
  President and CEO Harris Todd sold $12,000 worth of shares (500 units at $24.00), decreasing direct ownership by 0.03% to 1,477,373 units (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 578d
  President and CEO Harris Todd sold $283,223 worth of shares (11,747 units at $24.11), decreasing direct ownership by 0.79% to 1,477,873 units (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 583d
  President and CEO Harris Todd sold $394,441 worth of shares (16,307 units at $24.19), decreasing direct ownership by 1% to 1,489,620 units (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 586d
  President and CEO Harris Todd was granted 1,350 shares, increasing direct ownership by 0.09% to 1,505,927 units (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 586d
  Chief Financial Officer Fuhrman Alan was granted 954 shares, increasing direct ownership by 40% to 3,349 units (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 593d
  SEC Form 4 filed by Chief Medical Officer Warner Douglas J

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 618d
  SEC Form 4 filed by Chief Operating Officer Bensen Daniel

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 618d
  SEC Form 4 filed by President and CEO Harris Todd

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 618d
  SEC Form 4 filed by Chief Financial Officer Fuhrman Alan

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 677d
  Director Kaplan Gilla exercised 61,392 shares at a strike of $0.61, increasing direct ownership by 217% to 89,623 units (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 685d
  Chief Operating Officer Bensen Daniel sold $74,045 worth of shares (3,702 units at $20.00), decreasing direct ownership by 0.86% to 427,981 units (SEC Form 4)

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 695d
  SEC Form 4 filed by Ra Capital Management, L.P.

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 695d
  SEC Form 4 filed by Simson Jake

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 695d
  SEC Form 4 filed by More Robert J

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 695d
  SEC Form 4 filed by Subramony Siddarth

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 695d
  SEC Form 4 filed by Kjellson Nina S

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 695d
  SEC Form 4 filed by Verjee Rehan

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 695d
  SEC Form 4 filed by Kaplan Gilla

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 717d
  SEC Form 4 filed by Moran Susan

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
• 717d
  SEC Form 4 filed by Rothenberg Stephen Michael

  4 - Tyra Biosciences, Inc. (0001863127) (Issuer)

Other TYRA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends